Society issues guidance on ADR reporting
A new information sheet from the Royal Pharmaceutical Society gives guidance to pharmacists on reporting adverse drug reactions (ADRs). The fact
sheet is the seventh produced as part of the Society’s “Scientist
in the high street” campaign, which is designed to raise the
public profile of pharmacy as the embodiment of science in the community
setting.
The fact sheet points out that the Society’s Code of Ethics requires
pharmacists to be alert to potential ADRs and respond accordingly. It
says that pharmacists should use the yellow card scheme to report all
suspected ADRs for new “black triangle” products and all
serious suspected ADRs for established products. It adds that special
attention should be give to suspected ADRs in vulnerable groups such
as children, older people, pregnant women, nursing mothers and those
with a history of allergy. It also points out that suspected ADRs associated
with herbal medicines should be reported.
Copies of the fact sheet, printed on A4-size card, were sent out with
last week’s Pharmaceutical Journal to pharmacists who are listed
with the Society as being in community or hospital practice.
Pharmacists who have not received a copy of the card can obtain one by
sending a stamped, self-addressed C4 envelope to Judy Callanan, Royal
Pharmaceutical Society, 1 Lambeth High Street, London SE1 7JN.
As with the earlier fact sheets, a version can also be downloaded as
a PDF file from the science
section of the Society's website.
|
